MLTX Employees

MoonLake Immunotherapeutics had 100 employees as of December 31, 2024. The number of employees increased by 50 or 100.00% compared to the previous year.

Employees

100

Change (1Y)

Growth (1Y)

100.00%

Revenue / Employee

n/a

Profits / Employee

-$2,104,955

Market Cap

1.14B

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2024	100	50	100.00%
Dec 31, 2023	50	30	150.00%
Dec 31, 2022	20	-	-

Related Stocks

Company Name	Employees
AbCellera Biologics	596
Phathom Pharmaceuticals	427
Sana Biotechnology	194
Day One Biopharmaceuticals	184
EyePoint	165
Inhibrx Biosciences	161
Capricor Therapeutics	160
Inventiva	84

Employee Rankings

MLTX News

7 hours ago - MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day - GlobeNewsWire
6 days ago - Helix Acquisition Corp. III Announces Closing of $172.5 Million Initial Public Offering, Including the Full Exercise of the Underwriter's Option to Purchase Additional Shares - GlobeNewsWire
10 days ago - Helix Acquisition Corp. III Announces Pricing of Upsized $150 Million Initial Public Offering - GlobeNewsWire
24 days ago - MoonLake: Positive FDA Meeting Spurs Momentum Ahead Of BLA Submission - Seeking Alpha
25 days ago - MoonLake Says FDA May Allow Skin Drug Filing Without New Trials, Stock Soars - Benzinga
7 weeks ago - MOONLAKE DECEMBER 15th DEADLINE: Bragar Eagel & Squire, P.C. Urgently Reminds MoonLake Immunotherapeutics Investors to Contact the Firm - GlobeNewsWire
7 weeks ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics - GlobeNewsWire
7 weeks ago - DEADLINE NEXT WEEK: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Contact the Firm Before December 15, 2025 - PRNewsWire

More News